Join Brett Phinney, Ph.D., Director Proteomics Core Facility at University of California, Davis, CA, USA, as he discusses why column choice is critical in proteomics studies, and why choosing columns known for reproducibility, sensitivity and robustness is vital
Wondering what the paper “Noninvasive proteomic biomarkers for alcohol-related liver disease” in Nature Medicine and Brett Phinney, Ph.D., at the Proteomics Core Lab have in common?
They both solved column performance issues using the PepSep columns from Bruker:
Like these pioneers, you should not be held back from your proteomics breakthroughs due to column performance.
Join us and Director of Proteomics Core Facility at UC Davis, Brett Phinney, Ph.D, to explore how his lab elevates proteomics workflows through careful column selection. Phinney will also discuss how his column technology choices help the lab deliver its mission of
Afterwards join Michael Krawitzky, Ph.D., PepSep Product Manager, Bruker, and explore ways to “Power Up Your Proteomics Workflows”. When sample prep, separation, data acquisition and analysis come together. Discover how we are doing the heavy lifting to bring the best of proteomic workflows together so you can turn your attention to what matters... delivering results.
You don’t want to miss this one. Sign up now to secure your space.
Brett Phinney, Ph.D., Director Proteomics Core Facility, University of California, Davis, CA, USA
Michael Krawitzky, Ph.D., PepSep Product Manager, Bruker Scientific, LLC, San Jose, Ca, USA
For Research Use Only. Not for use in clinical diagnostic procedures.